This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Synergia Medical obtains funding from the European Commission (Horizon 2020)

July 18 2019

We are proud to share that our versatile neurostimulation technological platform will enjoy the support of Horizon 2020. It is an honor to take part in the (first) Phase-1 funding of the EU’s biggest research and innovation program. 

H2020 is a set of multiannual work programmes from the European Commission []

Synergia Medical is pioneering optoelectronics for neurostimulation medical devices by developing innovations to provide a powerful and versatile neurostimulation technological platform. Products derived from this platform would include a small non metallic encapsulation, wireless fast charging, custom optical lead, photovoltaic cells and an enhanced electrode.

This technology could benefit numerous therapeutic applications (such as drug-resistant epilepsy, sleep apnea or depression).